ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,608Medicare Part D Prescriptions Filled, Including Refills

Rank: 122 out of 2343

$1.02M Total Retail Price of All Prescriptions

Rank: 107 out of 2343

565 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 565 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

7% of this provider’s 565 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

0% of this provider’s 15,665 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
LISINOPRIL 796 708 1 3
AMLODIPINE BESYLATE 749 717 2 5
SIMVASTATIN 666 612 3 1
METOPROLOL SUCCINATE 660 621 4 14
WARFARIN SODIUM 531 512 5 8
LEVOTHYROXINE SODIUM 485 431 6 2
METOPROLOL TARTRATE 484 440 7 7
ATORVASTATIN CALCIUM 461 406 8 10
FUROSEMIDE 405 365 9 6
SERTRALINE HCL 396 342 10 20
METFORMIN HCL 351 323 11 9
ATENOLOL 323 316 12 12
PRAVASTATIN SODIUM 296 255 13 15
OMEPRAZOLE 295 272 14 4
LOSARTAN POTASSIUM 285 266 15 19
POTASSIUM CHLORIDE 284 264 16 18
DONEPEZIL HCL 274 251 17 21
TAMSULOSIN HCL 230 196 18 29
HYDROCHLOROTHIAZIDE 230 213 18 11
GABAPENTIN 200 132 20 16
KLOR-CON M20 161 149 21 44
AMILORIDE HCL 155 155 10 22 449
TORSEMIDE 155 147 22 157
CITALOPRAM HBR 151 127 24 17
INDAPAMIDE 149 129 25 170
ALLOPURINOL 135 127 26 31
ISOSORBIDE MONONITRATE ER 123 123 27 32
HYDROCODONE-ACETAMINOPHEN 121 96 S3 28 13
GLIMEPIRIDE 120 101 29 45
METFORMIN HCL ER 118 111 30 88
NEXIUM 118 99 30 33
CLONIDINE HCL 118 115 30 70
CLOPIDOGREL 115 108 33 26
SPIRONOLACTONE 112 101 34 65
FAMOTIDINE 111 98 35 60
BISOPROLOL FUMARATE 110 77 36 247
NAMENDA 108 108 37 36
DIGOXIN 108 104 37 35
BISOPROLOL-HYDROCHLOROTHIAZIDE 107 64 39 151
MELOXICAM 106 92 40 68
TRAMADOL HCL 102 82 41 25
DIOVAN 95 92 42 23
LANTUS 91 63 43 51
ZOLPIDEM TARTRATE 89 77 44 24
TRIAMTERENE-HCTZ 86 74 45 57
PRANDIN 81 78 46 140
FINASTERIDE 81 81 46 80
MIRTAZAPINE 78 53 48 41
PLAVIX 76 70 49 38
KLOR-CON 10 76 76 49 134
GLIPIZIDE XL 75 63 51 84
CRESTOR 74 65 52 30
FLUOXETINE HCL 73 44 53 82
DETROL LA 73 73 53 150
LIPITOR 73 70 53 78
PANTOPRAZOLE SODIUM 73 61 53 22
JANUVIA 72 68 57 50
DOXAZOSIN MESYLATE 71 71 58 98
BENICAR 71 54 58 93
ALENDRONATE SODIUM 69 62 60 28
LOVASTATIN 69 69 60 47
AZITHROMYCIN 67 61 62 39
LANTUS SOLOSTAR 67 65 62 101
RAMIPRIL 67 57 62 90
PEN NEEDLE 63 52 65 119
INSULIN SYRINGE 63 50 65 102
OXYCODONE-ACETAMINOPHEN 63 28 S2 65 49
COLCRYS 63 42 65 166
TRAMADOL HCL-ACETAMINOPHEN 62 48 69 199
SYNTHROID 60 49 70 40
FLUTICASONE PROPIONATE 58 47 71 46
BYSTOLIC 58 58 71 123
TRIAMCINOLONE ACETONIDE 57 49 73 137
QUETIAPINE FUMARATE 56 56 74 77
CLONIDINE 56 56 74 307
DILTIAZEM 24HR ER 55 55 76 76
TRICOR 55 55 76 96
DIOVAN HCT 54 54 78 63
HYDRALAZINE HCL 53 53 79 92
PREDNISONE 51 49 80 37
LABETALOL HCL 50 31 81 153
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 29, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.